These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23560157)

  • 1. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy.
    Ahn S; Hyeon J; Park CK
    Gut Liver; 2013 Mar; 7(2):206-12. PubMed ID: 23560157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection.
    Hyeon J; Ahn S; Park CK
    Korean J Pathol; 2013 Feb; 47(1):9-15. PubMed ID: 23482400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
    Ahn S; Hyeon J; Park CK
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
    Ha SY; Song DH; Hwang SH; Cho SY; Park CK
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
    Ha SY; Choi M; Lee T; Park CK
    Cancer Res Treat; 2016 Jan; 48(1):180-9. PubMed ID: 25797572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma.
    Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
    Korean J Pathol; 2013 Apr; 47(2):130-6. PubMed ID: 23667372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
    Kim SH; Ahn S; Park CK
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
    Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
    Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.
    Wang YY; Dong K; Wang K; Sun Y; Xing BC
    Dig Liver Dis; 2023 Sep; 55(9):1288-1294. PubMed ID: 37037766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
    Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
    Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of metadherin overexpression in hepatitis B virus-related hepatocellular carcinoma.
    Gong Z; Liu W; You N; Wang T; Wang X; Lu P; Zhao G; Yang P; Wang D; Dou K
    Oncol Rep; 2012 Jun; 27(6):2073-9. PubMed ID: 22470125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.
    Ha SY; Song DH; Lee JJ; Lee HW; Cho SY; Park CK
    Gut Liver; 2014 Nov; 8(6):648-54. PubMed ID: 25287169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas.
    Wang BL; Tan QW; Gao XH; Wu J; Guo W
    Asian Pac J Cancer Prev; 2014; 15(16):6673-8. PubMed ID: 25169507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metadherin promotes stem cell phenotypes and correlated with immune infiltration in hepatocellular carcinoma.
    Wang YY; Shen MM; Gao J
    World J Gastroenterol; 2024 Feb; 30(8):901-918. PubMed ID: 38516242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion.
    Zhou L; Wang SB; Chen SG; Qu Q; Rui JA
    Adv Clin Exp Med; 2020 Jul; 29(7):887-892. PubMed ID: 32750753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.
    Bang H; Ha SY; Hwang SH; Park CK
    Cancer Res Treat; 2015 Oct; 47(4):844-52. PubMed ID: 25687862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
    Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J
    Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
    Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
    BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Song K; He F; Xin Y; Guan G; Huo J; Zhu Q; Fan N; Guo Y; Zang Y; Wu L
    Pharmgenomics Pers Med; 2021; 14():269-278. PubMed ID: 33623416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.